Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in United States
118 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- Where
- Coral Springs, Denver, Grand Rapids, Houston, Los Angeles, Miami, Nashville, Philadelphia, Sacramento, Tampa
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Prelude Therapeutics Incorporated
See details and how to joinNCT07469891 · EU 2026-525484-40-00 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Age
- 18 years to 120 years
- People
- 15,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - Phase 1Taking peopleAlloHCT With PegINFa for Myelofibrosis
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 18
- Run by
- University of Utah
See details and how to joinNCT05535764 - Phase 2Taking peopleA Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Where
- Charlotte, Chicago, Columbus, Concord, Coral Gables, Coral Springs, Crown Point, Deerfield Beach, Doral, Fairway, Hollywood, Irvine, Kansas City, Miami, Nashville, New Lenox, New York, North Miami, Oklahoma City, Orange, Orland Park, Overland Park, Palo Alto, Plantation, Portland, Richmond, Sacramento, Salt Lake City, Tampa, Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 78
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06661915 - Phase 2Taking peopleSelinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
- Where
- New York, Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 26
- Run by
- John Mascarenhas
See details and how to joinNCT07447817 - Phase 1Not yet taking people in United StatesA Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Where
- Ann Arbor, Atlanta, Babylon, Baltimore, Birmingham, Boston, Charlotte, Columbus, Duarte, Durham, Eugene, Gilbert, Houston, Irvine, Kansas City, Nashville, New York, Richmond, Salt Lake City, Seattle, St Louis, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Damora Therapeutics
See details and how to joinNCT07849231 - Phase 2Taking peopleCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Where
- Seattle
- Age
- 6 months to 65 years
- People
- 54
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06013423 - Phase 1/2Taking peopleTreating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
- Where
- Orange
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, Irvine
See details and how to joinNCT07281781 - Phase 2Taking peopleCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 216
- Run by
- City of Hope Medical Center
See details and how to joinNCT06059391 - Phase 1Taking peopleA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 46
- Run by
- City of Hope Medical Center
See details and how to joinNCT07020533 - Phase 1/2Taking peopleStudy of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Where
- Ann Arbor, Atlanta, Aurora, Canton, Cleveland, Columbus, Duarte, East Brunswick, Gettysburg, Gilbert, Houston, Iowa City, Irvine, Jacksonville, Los Angeles, Maumee, Miami, Milwaukee, New York, Philadelphia, Portland, Rochester, Rolling Meadows, San Francisco, Seattle, St Louis, Tampa, Temple, Winston-Salem
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Disc Medicine, Inc
See details and how to joinNCT05320198 - Phase 1Taking peopleLeading in MPNs Beyond Ruxolitinib in Combo With T-Regs
- Where
- Houston, New York, Sacramento, The Bronx
- Age
- 18 years and over
- People
- 24
- Run by
- Cellenkos, Inc.
See details and how to joinNCT05423691 - Phase 1Taking peopleCER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Where
- Denver, Houston, Nashville, Sacramento, Seattle
- Age
- 18 years to 85 years
- People
- 18
- Run by
- CERo Therapeutics Holdings, Inc.
See details and how to joinNCT06834282 - Phase 1Taking peopleTherapeutic RSK1 Targeting in Myeloid Malignancies
- Where
- St Louis
- Age
- 18 years and over
- People
- 30
- Run by
- Washington University School of Medicine
See details and how to joinNCT07379125 - Phase 1Not yet taking people in United StatesPhase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms
- Where
- Buffalo
- Age
- 18 years and over
- People
- 20
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT07679334 - No phaseTaking peoplePacritinib Effectiveness in Real-world Settings
- Where
- Charleston, Columbus, Nashville, New Haven, Tampa
- Age
- 18 years and over
- People
- 60
- Run by
- Swedish Orphan Biovitrum
See details and how to joinNCT07774455 - Phase 2Taking peopleGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Where
- Pittsburgh, Seattle, Tampa
- Age
- 1 year to 60 years
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03970096 - No phaseTaking peopleBrain MRF in Children, Adolescents and Young Adults With Acute Leukemia
- Where
- Cleveland
- Age
- Up to 30 years
- People
- 20
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06421155 - Phase 2Taking peopleRuxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- Where
- Seattle
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07228624 - Phase 1Taking peopleTolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 15
- Run by
- University of Utah
See details and how to joinNCT07521046 - No phaseTaking peopleLeukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Where
- Chicago, Miami, San Antonio
- Age
- 18 years and over
- People
- 400
- Run by
- University of Miami
See details and how to joinNCT05745285 - Phase 2Not yet taking people in United StatesOral Tetrahydrouridine-Decitabine in Patients With Advanced Myeloproliferative Neoplasms
- Where
- New York
- Age
- 18 years and over
- People
- 20
- Run by
- John Mascarenhas
See details and how to joinNCT07872709 - Phase 2Not yet taking people in United StatesA Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 450
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07572929 - Phase 2Taking peopleTrial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
- Where
- Birmingham
- Age
- 18 years to 60 years
- People
- 29
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06315309 - Phase 1/2Taking peoplePhase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
- Where
- Houston
- Age
- 18 years and over
- People
- 66
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07128381